Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer

NCT00105456 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00105456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00105456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2003
Completion date
May 31, 2009
Enrollment
1,000
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer